未登录

J

Jane Xu

sunovion pharmaceuticals inc.

H指数:16

被引数:1,403

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma

PRECISION CLINICAL MEDICINE

IF5

2023-03-104

OAAI

National trends and clinical outcomes of interventional approaches following admission for infected necrotizing pancreatitis in the United States

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY

IF3.7

2023-02-204

PRE

The Evil Pleasure: Abusive Supervision and Third-Party Observers' Malicious Reactions Toward Victims

ORGANIZATION SCIENCE

IF5.4

2020-09-0150

OAAI

Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study

利培酮治疗12个月后改用鲁拉西酮: 一项为期6个月的开放标签研究的结果

IF3.6

2020-05-0516

OAAI

Efficacy of lurasidone across five symptom dimensions of schizophrenia: Pooled analysis of short-term, placebo-controlled studies

EUROPEAN PSYCHIATRY

IF6.7

2020-04-1525

PREAI

Gastric Cancer Peritoneal Carcinomatosis Risk Score

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2019-07-2522

OAAI

Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation

IF3.6

2015-10-3115

OAAI

Delusional disorder and schizophrenia: a comparison of the neurocognitive and clinical characteristics in first-episode patients

PSYCHOLOGICAL MEDICINE

IF5.5

2015-06-0319

PREAI

An open-label extension study of lurasidone in patients with schizophrenia previously randomized to lurasidone or risperidone

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2014-10-010

PREAI

Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2014-02-01180

PREAI

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study

SCHIZOPHRENIA RESEARCH

IF3.5

2013-06-0191

OAAI

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study

JOURNAL OF PSYCHIATRIC RESEARCH

IF3.2

2013-05-01118

PREAI

EFFECT OF LURASIDONE ON WEIGHT AND METABOLIC PARAMETERS: A COMPREHENSIVE DATABASE ANALYSIS

SCHIZOPHRENIA RESEARCH

IF3.5

2012-04-012

PREAI

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2011-09-01204

PREAI

LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL

SCHIZOPHRENIA RESEARCH

IF3.5

2010-04-012

PREAI

Characterizing the grape transcriptome. Analysis of expressed sequence tags from multiple vitis species and development of a compendium of gene expression during berry development

PLANT PHYSIOLOGY

IF6.9

2005-10-11162

OAAI